|
US7011812B1
(en)
|
1996-05-03 |
2006-03-14 |
Immunomedics, Inc. |
Targeted combination immunotherapy of cancer and infectious diseases
|
|
US7736651B1
(en)
|
2000-11-24 |
2010-06-15 |
Sloan-Kettering Institute For Cancer Research |
Alpha emitting constructs and uses thereof
|
|
EP1173192B1
(en)
|
1999-03-08 |
2018-08-15 |
Gerhart Graupner |
Methods and compositions for targeted drug delivery
|
|
CA2391534A1
(en)
|
1999-11-15 |
2001-05-25 |
Drug Innovation & Design, Inc. |
Selective cellular targeting: multifunctional delivery vehicles
|
|
US6683162B2
(en)
|
2000-09-15 |
2004-01-27 |
Sloan Kettering Institute Of Cancer Research |
Targeted alpha particle therapy using actinium-255 conjugates
|
|
US7138496B2
(en)
|
2002-02-08 |
2006-11-21 |
Genetastix Corporation |
Human monoclonal antibodies against human CXCR4
|
|
WO2002098897A2
(en)
|
2001-06-01 |
2002-12-12 |
Cornell Research Foundation, Inc. |
Modified antibodies to prostate-specific membrane antigen and uses thereof
|
|
US7666414B2
(en)
|
2001-06-01 |
2010-02-23 |
Cornell Research Foundation, Inc. |
Methods for treating prostate cancer using modified antibodies to prostate-specific membrane antigen
|
|
US7514078B2
(en)
*
|
2001-06-01 |
2009-04-07 |
Cornell Research Foundation, Inc. |
Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
|
|
EP1427377A4
(en)
|
2001-09-20 |
2006-04-12 |
Cornell Res Foundation Inc |
METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING SKIN DISORDERS USING SPECIFIC BINDING AGENTS FOR A PROSTATE-SPECIFIC MEMBRANE ANTIGEN
|
|
WO2005070456A2
(en)
|
2004-01-09 |
2005-08-04 |
Millennium Pharmaceuticals, Inc. |
Diagnosing and treating female reproductive tract or chilhood cancer with pmsa antibodies
|
|
WO2007044616A2
(en)
|
2005-10-06 |
2007-04-19 |
Xencor, Inc. |
Optimized anti-cd30 antibodies
|
|
NO20220050A1
(no)
|
2005-11-21 |
2008-08-12 |
Novartis Ag |
Neuroendokrin tumorbehandling
|
|
EP2132133A4
(en)
|
2007-03-02 |
2013-04-17 |
Univ Illinois |
RELEASE OF PARTICULATE ACTIVE SUBSTANCES
|
|
ES2700234T3
(es)
|
2007-06-26 |
2019-02-14 |
Univ Johns Hopkins |
Inhibidores marcados del antígeno de membrana específico de la próstata (PSMA), evaluación biológica y uso como agentes para la obtención de imágenes
|
|
PT2318366T
(pt)
|
2008-08-01 |
2017-08-02 |
Univ Johns Hopkins |
Agentes de ligação a psma e suas utilizações
|
|
US8889631B2
(en)
|
2008-08-18 |
2014-11-18 |
The University Of Kansas |
Disruptors of early/recycling endosomes
|
|
US9056841B2
(en)
|
2009-03-19 |
2015-06-16 |
The Johns Hopkins University |
PSMA-targeting compounds and uses thereof
|
|
US10717750B2
(en)
|
2009-03-19 |
2020-07-21 |
The Johns Hopkins University |
68Ga-labeled NOTA-chelated PSMA-targeted imaging and therapeutic agents
|
|
JP2013504585A
(ja)
|
2009-09-09 |
2013-02-07 |
セントローズ， エルエルシー |
細胞外標的化薬物複合体
|
|
WO2011108955A1
(en)
|
2010-03-03 |
2011-09-09 |
Universidade De Coimbra |
Multi -targeting system comprising a nanocarrier, nucleic acid(s) and non-nucleic acid based drug(s)
|
|
CA2841120C
(en)
|
2011-07-11 |
2020-10-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Antibody-ir700 conjugates for photodynamic therapy
|
|
AU2012294639B2
(en)
|
2011-08-05 |
2017-10-26 |
Molecular Insight Pharmaceuticals, Inc. |
Radiolabeled prostate specific membrane antigen inhibitors
|
|
EP2800586A1
(en)
|
2012-01-03 |
2014-11-12 |
Invictus Oncology Pvt. Ltd. |
Ligand-targeted molecules and methods thereof
|
|
CA2869748C
(en)
|
2012-04-12 |
2017-10-24 |
Yale University |
Vehicles for controlled delivery of different pharmaceutical agents
|
|
WO2014001326A1
(en)
|
2012-06-27 |
2014-01-03 |
F. Hoffmann-La Roche Ag |
Method for the selection and production of tailor-made, selective and multi-specific therapeutic molecules comprising at least two different targeting entities and uses thereof
|
|
US8990921B2
(en)
|
2013-02-21 |
2015-03-24 |
Atheer, Inc. |
Apparatus for processing with a secure system manager
|
|
JP6239246B2
(ja)
*
|
2013-03-13 |
2017-11-29 |
株式会社日立ハイテクノロジーズ |
荷電粒子線装置、試料観察方法、試料台、観察システム、および発光部材
|
|
CN105283201B
(zh)
|
2013-03-14 |
2019-08-02 |
斯克利普斯研究所 |
靶向剂抗体偶联物及其用途
|
|
US9636419B2
(en)
|
2013-10-11 |
2017-05-02 |
The Universit of Kansas |
Targeting multiple receptors on a cell surface for specific cell targeting
|
|
EP3456700A1
(en)
|
2013-10-18 |
2019-03-20 |
Deutsches Krebsforschungszentrum |
Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
|
|
JP6908964B2
(ja)
*
|
2013-10-18 |
2021-07-28 |
ピーエスエムエー ディベロップメント カンパニー，エルエルシー |
Ｐｓｍａリガンドコンジュゲートによる併用療法
|
|
US20150110814A1
(en)
|
2013-10-18 |
2015-04-23 |
Psma Development Company, Llc |
Combination therapies with psma ligand conjugates
|
|
EP3129065A4
(en)
|
2014-03-12 |
2018-01-24 |
Invictus Oncology Pvt. Ltd. |
Targeted drug delivery through affinity based linkers
|
|
CN106660943B
(zh)
|
2014-05-06 |
2020-03-17 |
约翰霍普金斯大学 |
用于psma靶向的成像和放射疗法的金属/放射性金属标记的psma抑制物
|
|
EP3200823B1
(en)
|
2014-10-02 |
2022-11-23 |
City of Hope |
Multivalent meditopes, meditope-binding antibodies and uses thereof
|
|
EP3209336B1
(en)
|
2014-10-20 |
2019-12-11 |
Deutsches Krebsforschungszentrum |
18f-tagged inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
|
|
WO2016123593A1
(en)
|
2015-01-30 |
2016-08-04 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
|
IL237525A
(en)
|
2015-03-03 |
2017-05-29 |
Shalom Eli |
Method for labeling a prostate-specific membrane antigen with a radioactive isotope
|
|
US10688200B2
(en)
|
2015-12-31 |
2020-06-23 |
Five Eleven Pharma Inc. |
Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and therapy
|
|
RS65188B1
(sr)
|
2016-03-22 |
2024-03-29 |
Univ Johns Hopkins |
Sredstva sa visokim afinitetom za ciljano dejstvo na membranski antigen specifičan za prostatu za endoradioterapiju kancera prostate
|
|
CN109843339B
(zh)
|
2016-06-23 |
2023-07-07 |
康奈尔大学 |
影响肿瘤杀伤的双重靶向构建体
|
|
GB201614162D0
(en)
|
2016-08-18 |
2016-10-05 |
Polytherics Ltd |
Antibodies, uses thereof and conjugates thereof
|
|
WO2018108287A1
(en)
|
2016-12-15 |
2018-06-21 |
The European Atomic Energy Community (Euratom), Represented By The European Commission |
Treatment of pmsa expressing cancers
|
|
WO2018204477A1
(en)
|
2017-05-02 |
2018-11-08 |
Cornell University |
Methods and reagents for tumor targeting with greater efficacy and less toxicity
|
|
US20200339625A1
(en)
|
2017-10-22 |
2020-10-29 |
Provincial Health Services Authority |
Novel radiometal-binding compounds for diagnosis or treatment of prostate specific membrane antigen-expressing cancer
|
|
SG11202106603UA
(en)
|
2018-12-21 |
2021-07-29 |
Sapreme Tech Bv |
Biologically active cluster of molecules
|
|
US11478493B2
(en)
|
2019-03-08 |
2022-10-25 |
University Of South Carolina |
Fabrication and application of a hetero-targeted nano-cocktail with traceless linkers
|
|
US20220081401A1
(en)
|
2019-05-29 |
2022-03-17 |
University Of Tennessee Research Foundation |
Selective androgen receptor degrader (sard) ligands and methods of use thereof
|
|
JP2023547998A
(ja)
|
2020-10-01 |
2023-11-15 |
コーネル ユニバーシティー |
低分子リガンドの取り込み、内在化、及び／または保持を増加させるための方法及び組成物
|
|
US20240000979A1
(en)
|
2020-10-01 |
2024-01-04 |
Cornell University |
Methods and compositions for synergistic uptake and retention of small molecule ligands
|